This study is researching an experimental drug called cemiplimab. The study is focused on Cutaneous Squamous Cell Carcinoma (CSCC) and Basal Cell Carcinoma (BCC). The aim of the study is to evaluate the safety and tolerability (how your body reacts to the drug) of cemiplimab (also known as REGN2810). The first part of the study tested several different doses of cemiplimab given weekly for 12 weeks. The study is also looking at several other research questions, including: * What side effects may happen from taking the study drug * To see effect of cemiplimab on the tumor * How much study drug is in the blood at different times
Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma
This study is researching an experimental drug called cemiplimab. The study is focused on Cutaneous Squamous Cell Carcinoma (CSCC) and Basal Cell Carcinoma (BCC). The aim of the study is to evaluate the safety and tolerability (how your body reacts to the drug) of cemiplimab (also known as REGN2810). The first part of the study tested several different doses of cemiplimab given weekly for 12 weeks. The study is also looking at several other research questions, including: * What side effects may happen from taking the study drug * To see effect of cemiplimab on the tumor * How much study drug is in the blood at different times
Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma
-
Medical Dermatology Specialists, Phoenix, Arizona, United States, 85006
Stanford University School of Medicine, Redwood City, California, United States, 94063
Therapeutics Clinical Research, San Diego, California, United States, 92123
Dermatology Associates of the Palm Beaches, Delray Beach, Florida, United States, 33445
H. Lee Moffitt Cancer Center, Tampa, Florida, United States, 33612
MetroDerm P.C., Atlanta, Georgia, United States, 30342
Norton Healthcare, Louisville, Kentucky, United States, 40202
Northeast Dermatology Associates, Beverly, Massachusetts, United States, 01915
NYU Langone, New York, New York, United States, 10017
Rochester Dermatologic Surgery, Victor, New York, United States, 14564
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Regeneron Pharmaceuticals,
Clinical Trial Management, STUDY_DIRECTOR, Regeneron Pharmaceuticals
2027-10-22